-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
7 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$224,917
Nektar Therapeutics Insider Transactions
Nektar Therapeutics Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
CHESS ROBERT
Director |
Sell | 19,500 @ $1.20 | $23,400 | 255,273 | 06/14/2024 | 06/14/2024 | |
|
ROBIN HOWARD W
CEO |
Sell | 16,650 @ $1.75 | $29,138 | 863,239 | 05/17/2024 | 05/20/2024 | |
|
Wilson Mark Andrew
Chief Legal Officer |
Sell | 6,260 @ $1.75 | $10,955 | 230,414 | 05/17/2024 | 05/20/2024 | |
|
Zalevsky Jonathan
Chief R&D Officer |
Sell | 7,355 @ $1.75 | $12,871 | 257,670 | 05/17/2024 | 05/20/2024 | |
|
Deep Track Capital, LP
10 percent owner |
Sell | 56,000 @ $1.78 | $99,630 | 18,344,000 | 05/10/2024 | 05/13/2024 | |
|
Zalevsky Jonathan
Chief R&D Officer |
Sell | 9,014 @ $0.68 | $6,130 | 265,025 | 02/20/2024 | 02/22/2024 | |
|
Wilson Mark Andrew
Chief Legal Officer |
Sell | 7,606 @ $0.68 | $5,172 | 236,674 | 02/20/2024 | 02/22/2024 | |
|
ROBIN HOWARD W
CEO |
Sell | 20,033 @ $0.68 | $13,622 | 879,889 | 02/20/2024 | 02/22/2024 | |
|
Zalevsky Jonathan
Chief R&D Officer |
Sell | 9,646 @ $0.49 | $4,727 | 274,039 | 11/17/2023 | 11/20/2023 | |
|
Wilson Mark Andrew
Chief Legal Officer |
Sell | 7,179 @ $0.49 | $3,518 | 243,780 | 11/17/2023 | 11/20/2023 | |
|
ROBIN HOWARD W
CEO |
Sell | 19,877 @ $0.49 | $9,740 | 899,922 | 11/17/2023 | 11/20/2023 | |
|
Curet Myriam
Director |
Sell | 4,359 @ $0.69 | $3,008 | 27,418 | 09/18/2023 | 09/20/2023 | |
|
Ajer Jeffrey Robert
Director |
Sell | 4,359 @ $0.69 | $3,008 | 34,153 | 09/18/2023 | 09/20/2023 | |
|
Zalevsky Jonathan
Chief R&D Officer |
Sell | 9,703 @ $0.78 | $7,568 | 283,685 | 08/16/2023 | 08/17/2023 | |
|
Wilson Mark Andrew
Chief Legal Officer |
Sell | 7,221 @ $0.78 | $5,632 | 250,959 | 08/16/2023 | 08/17/2023 | |
|
ROBIN HOWARD W
CEO |
Sell | 19,998 @ $0.78 | $15,598 | 919,799 | 08/16/2023 | 08/17/2023 | |
|
WHITFIELD ROY A
Director |
Sell | 30,000 @ $0.57 | $17,100 | 216,250 | 06/14/2023 | 06/15/2023 | |
|
Zalevsky Jonathan
Chief R&D Officer |
Sell | 9,791 @ $0.72 | $7,050 | 293,388 | 05/16/2023 | 05/17/2023 | |
|
Wilson Mark Andrew
Chief Legal Officer |
Sell | 7,543 @ $0.72 | $5,431 | 257,680 | 05/16/2023 | 05/17/2023 | |
|
ROBIN HOWARD W
CEO |
Sell | 20,361 @ $0.72 | $14,660 | 939,797 | 05/16/2023 | 05/17/2023 |
Nektar Therapeutics Frequently Asked Questions
-
Who is on Nektar Therapeutics's Insider Roster?
The list of insiders at Nektar Therapeutics includes Ajer Jeffrey Robert, Curet Myriam, ROBIN HOWARD W, Wilson Mark Andrew, Zalevsky Jonathan, Deep Track Capital, LP, CHESS ROBERT.
-
How much insider selling is happening at Nektar Therapeutics?
Insiders have sold a total of 187,838 Nektar Therapeutics shares in the last 12 months for a total of 224,917 sold.
-
Which Nektar Therapeutics insiders have been selling company stock?
The following insiders have sold Nektar Therapeutics shares in the last 12 months: Ajer Jeffrey Robert ($3,008), Curet Myriam ($3,008), ROBIN HOWARD W ($52,500), Wilson Mark Andrew ($19,645), Zalevsky Jonathan ($23,727), Deep Track Capital, LP ($99,630), CHESS ROBERT ($23,400),